<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess the prevalence and clinical predictors of silent <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e> in asymptomatic patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and to test the effectiveness of current American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association screening guidelines </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: In the Detection of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e> in Asymptomatic Diabetics (DIAD) study, 1,123 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, aged 50-75 years, with no known or suspected <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo>, were randomly assigned to either stress testing and 5-year clinical follow-up or to follow-up only </plain></SENT>
<SENT sid="2" pm="."><plain>The prevalence of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in 522 patients randomized to stress testing was assessed by <z:chebi fb="3" ids="16335">adenosine</z:chebi> <z:chebi fb="1" ids="33353">technetium</z:chebi>-99m sestamibi single-<z:chebi fb="23" ids="30212">photon</z:chebi> emission-computed tomography myocardial perfusion imaging </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: A total of 113 patients (22%) had silent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, including 83 with regional myocardial perfusion abnormalities and 30 with <z:mpath ids='MPATH_458'>normal</z:mpath> perfusion but other abnormalities (i.e., <z:chebi fb="3" ids="16335">adenosine</z:chebi>-induced ST-segment <z:hpo ids='HP_0000716'>depression</z:hpo>, ventricular dilation, or rest ventricular dysfunction) </plain></SENT>
<SENT sid="4" pm="."><plain>Moderate or large perfusion defects were present in 33 patients </plain></SENT>
<SENT sid="5" pm="."><plain>The strongest predictors for abnormal tests were abnormal Valsalva (odds ratio [OR] 5.6), male sex (2.5), and <z:mp ids='MP_0002055'>diabetes</z:mp> duration (5.2) </plain></SENT>
<SENT sid="6" pm="."><plain>Other traditional cardiac risk factors or inflammatory and prothrombotic markers were not predictive </plain></SENT>
<SENT sid="7" pm="."><plain>Ischemic <z:chebi fb="3" ids="16335">adenosine</z:chebi>-induced ST-segment <z:hpo ids='HP_0000716'>depression</z:hpo> with <z:mpath ids='MPATH_458'>normal</z:mpath> perfusion (n = 21) was associated with women (OR 3.4) </plain></SENT>
<SENT sid="8" pm="."><plain>Selecting only patients who met American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association guidelines would have failed to identify 41% of patients with silent <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Silent <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e> occurs in greater than one in five asymptomatic patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Traditional and emerging cardiac risk factors were not associated with abnormal stress tests, although cardiac <z:hpo ids='HP_0002459'>autonomic dysfunction</z:hpo> was a strong predictor of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>